New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

The Tulane team has developed a handful of other assays for TB detection, including mass spec test for paucibacillary TB that ...

The Tulane team has developed a handful of other assays for TB detection, including mass spec test for paucibacillary TB that is being commercialized by Nanopin Tech, and a non-sputum CRISPR-based lab ...

Pharmaceutical imports are expected to reach $920m by 2029. Pakistan’s reliance on pharmaceutical imports is expected to ...

A new study by University of Bath scientists has highlighted two new potential families of drug molecules that could open the ...

The researchers identified several ways to strengthen peer-led TB efforts, including expanding mobile diagnostic services, integrating TB care into methadone clinics and offering small financial ...

Image=KCDC Amid the increased possibility of using artificial intelligence (AI) for care due to aging, a senior medication ...

Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB ...

A new article published in Nature offers a promising path toward a shorter, more effective treatment for tuberculosis (TB), a ...

The emergence of multidrug- and extensively drug-resistant strains of Mycobacterium tuberculosis highlights the need to discover new antitubercular agents. Here we describe the synthesis and ...

In another randomized clinical trial, TMC207 was given as part of a multidrug treatment together with an individualized background regimen of second-line TB drugs at a daily oral dose of 400 mg ...

TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of ...